The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

However, most people get infected with TB don’t get sick, according to NCDHSS. That’s because their bodies can fight the ...

Tuberculosis is making headlines as the contagious respiratory disease spreads in the Midwest. Kansas is currently facing one ...

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...

A symptom of COVID is the loss of taste or smell. Tuberculosis has a longer incubation period, and the symptoms have a much ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Vitamin D supplementation during TB treatment improves patient symptoms, but does not accelerate the clearance of TB bacteria.

ND health officials say tuberculosis spreads slowly, urging people to get screened after a recent outbreak in Kansas.

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...